T
48.69
-2.15 (-4.23%)
| Previous Close | 50.84 |
| Open | 50.11 |
| Volume | 4,623,240 |
| Avg. Volume (3M) | 5,372,627 |
| Market Cap | 8,704,491,520 |
| Price / Sales | 6.85 |
| Price / Book | 18.19 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2026 |
| Profit Margin | -88.27% |
| Operating Margin (TTM) | -26.93% |
| Diluted EPS (TTM) | -5.16 |
| Quarterly Revenue Growth (YOY) | 75.40% |
| Total Debt/Equity (MRQ) | 262.96% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | -193.29 M |
| Levered Free Cash Flow (TTM) | 54.30 M |
| Return on Assets (TTM) | -43.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | Tempus AI, Inc. | Bearish | Bullish |
AIStockmoo Score
-0.1
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.13 |
|
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Mid Growth |
| % Held by Insiders | 43.27% |
| % Held by Institutions | 38.33% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Gc Wealth Management Ria, Llc | 31 Dec 2025 | 6,761,507 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 100.00 (Mizuho, 105.38%) | Buy |
| Median | 77.50 (59.17%) | |
| Low | 59.00 (Baird, 21.18%) | Buy |
| Average | 78.63 (61.49%) | |
| Total | 7 Buy, 1 Hold | |
| Avg. Price @ Call | 55.28 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Needham | 11 Mar 2026 | 75.00 (54.04%) | Buy | 52.68 |
| 25 Feb 2026 | 75.00 (54.04%) | Buy | 53.71 | |
| HC Wainwright & Co. | 09 Mar 2026 | 95.00 (95.11%) | Buy | 52.32 |
| Morgan Stanley | 03 Mar 2026 | 70.00 (43.77%) | Buy | 51.40 |
| BTIG | 25 Feb 2026 | 90.00 (84.84%) | Buy | 53.71 |
| JP Morgan | 25 Feb 2026 | 60.00 (23.23%) | Hold | 53.71 |
| Mizuho | 19 Feb 2026 | 100.00 (105.38%) | Buy | 59.96 |
| Baird | 17 Feb 2026 | 59.00 (21.17%) | Buy | 52.56 |
| Canaccord Genuity | 22 Dec 2025 | 80.00 (64.30%) | Buy | 65.92 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |